South Korean biopharmaceutical research company in the Guro district of Seoul, founded in December 2005, which works on macromolecule transduction domain peptides that carry proteins and other large molecules through cell membranes. Applies the technology to anti cancer protein candidates, transdermal delivery and cosmetic ingredients, holds patents on it in the United States, China, Japan and Europe, and has been part of the Bioplus group since 2022.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen